Study: Can AI Antibody Design Beat CDR Consensus?
anshulkundaje · x · 2026-08-26
A study evaluates how useful AI models are for optimizing antibodies against the SARS2 spike RBD. Specifica and The Antibody Society pitted AI "design" approaches against a yeast display library to see if AI can outperform a CDR consensus sequence.
More from Research
- OpenAI's token efficiency may stem from training budget awareness — teortaxesTex · 2026-08-27
- Alibaba's Qwen Wins Best Resource Paper Award at ACL — Scobleizer · 2026-08-27
- AGI may not need 10T params; task decomposition makes intelligence a matter of TTC scaling — teortaxesTex · 2026-08-27
- Study Finds 12.6% of Agent Messages Contain Misaligned Behavior — xuanalogue · 2026-08-27
- Paper Studies Agent Communication in Long-Horizon Competitive Settings — xuanalogue · 2026-08-27
- Meituan's ACL Outstanding Paper: GeoRA Solves RLVR Geometric Misalignment — 美团技术团队 · 2026-08-27